Front of Line Access to the MiniMed 670G System

Want to get front of the line access to the MiniMed 670G system when it becomes available in the spring? Here’s how!

In this video, Naomi and I explain the new Priority Access program. Visit www.medtronicdiabetes.com/priority-access to learn more.

Editors Note: Due to overwhelming demand, we’ve been able to extend this program to customers through January 31, 2017!

 
Important Safety Information

The MiniMed 530G and 630G systems with SmartGuard technology are intended for the delivery of insulin and continuous glucose (CGM) monitoring for the management of diabetes mellitus in persons 16 years of age or older who require insulin. Insulin infusion pumps and associated components of insulin infusion systems are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks of insulin pump therapy. The systems are not intended to be used directly for preventing or treating hypoglycemia but to suspend insulin delivery when the user is unable to respond to the Threshold suspend (530G) or Suspend on low (630G) alarm and take measures to prevent or treat hypoglycemia themselves. The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a blood glucose meter. A confirmatory fingerstick via a CONTOUR®NEXT LINK portfolio meter*, is required prior to making adjustments to diabetes therapy. Always check the pump display when using a CONTOUR®NEXT LINK portfolio meter*, to ensure the glucose result shown agrees with the glucose results shown on the meter. Additional, warnings, precautions and contraindications apply. See www.medtronicdiabetes.com/support/download-library/user-guides and www.medtronicdiabetes.com/importantsafetyinformation for details.
MiniMed® 670G System
The Medtronic MiniMed 670G system requires a prescription and is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of Type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G System includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values.
The Guardian Sensor (3) is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a finger stick may be required. All therapy adjustments should be based on measurements obtained using a home glucose monitor and not on values provided by the Guardian Sensor (3).
WARNING: Medtronic performed an evaluation of the MiniMed 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Do not use the serter on products other than the Enlite sensor or Guardian Sensor (3). Medtronic cannot guarantee the safety or efficacy of this product if used with other products. The reservoir is contraindicated for the infusion of blood or blood products. Infusion sets are indicated for subcutaneous use only and not for intravenous (IV) infusion or the infusion of blood or blood products. Insulin pump therapy is not recommended for those who are unwilling to perform at least four blood glucose tests per day. As insulin pumps use rapid acting insulin only, BG testing is required to help identify rapid glycemic deterioration due to insulin infusion occlusion, infusion site problems, insulin stability issues, user error, or a combination of these. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional.
The safety of the 670G system has not been studied in people with impaired kidney function. Please let your healthcare professional know if you have kidney disease so you and your healthcare professional can determine if the potential benefits of using the system outweigh the risks. The safety of the 670G system has not been studied in pregnant women, people with type 2 diabetes, or in people using other anti-hyperglycemic therapies apart from insulin. Please let your healthcare professional know if any of these conditions apply to you so you and your healthcare professional can determine if the potential benefits of using the system outweigh the risks.
For complete safety information, please consult the appropriate User Guide.
*The CONTOUR®NEXT LINK 2.4 Meter is used with the MiniMed 630G system. The CONTOUR®NEXT LINK Meter is used with the MiniMed 530G system.

Print This Post Print This Post
Tags: , , , ,
Latest Comments
  1. Avatar Robin Suarez
    • Avatar Karrie Hawbaker
      • Avatar Will Alfieri
        • Avatar Karrie Hawbaker
          • Avatar Will Alfieri
          • Avatar Karrie Hawbaker
  2. Avatar Patricia Thomas
    • Avatar Karrie Hawbaker
  3. Avatar James Chamblee
    • Avatar Karrie Hawbaker
  4. Avatar John Graham
    • Avatar Kim hintos
      • Avatar Sherrie Bassignani
        • Avatar Karrie Hawbaker
  5. Avatar Sofía
    • Avatar Karrie Hawbaker
  6. Avatar Kelli
    • Avatar Karrie Hawbaker
  7. Avatar Philip barradell
    • Avatar Karrie Hawbaker
  8. Avatar Brittany
    • Avatar Karrie Hawbaker
    • Avatar Karrie Hawbaker
    • Avatar Karrie Hawbaker
  9. Avatar Steven Rubenstein
    • Avatar Karrie Hawbaker
  10. Avatar Theresa Garcia
    • Avatar Karrie Hawbaker
  11. Avatar Tim Vargo
    • Avatar Tim Vargo
    • Avatar Karrie Hawbaker
  12. Avatar Rylie Pena
    • Avatar Karrie Hawbaker
  13. Avatar Dana Reynolds
    • Avatar Karrie Hawbaker
  14. Avatar Cheryl McCarthy
    • Avatar Karrie Hawbaker
  15. Avatar Theresa Garcia
    • Avatar Karrie Hawbaker
  16. Avatar Theresa Garcia
    • Avatar Karrie Hawbaker
    • Avatar Karrie Hawbaker
  17. Avatar Theresa Garcia
  18. Avatar Alecia Heidt
    • Avatar Karrie Hawbaker
  19. Avatar Theresa Garcia
    • Avatar Karrie Hawbaker
  20. Avatar Liliana Sarantos
    • Avatar Karrie Hawbaker
  21. Avatar Theresa Garcia
    • Avatar Karrie Hawbaker
      • Avatar Theresa Garcia
  22. Avatar Theresa Garcia
    • Avatar Karrie Hawbaker
  23. Avatar Beverly Hilliard
    • Avatar Karrie Hawbaker

Post A Comment

Your email address will not be published. Required fields are marked *